Latest | F'cast | |
---|---|---|
Div Yield | 0.5% | |
Div Cover | 4.0 | |
Op Mrgn | 23.6% | |
ROCE | 33.1% |
Latest | F'cast | |
---|---|---|
P/E | 45.6 | |
PEG | 0.2 | |
Pr/Revenue | 8.7 | |
Pr/Book | 4.8 |
Latest | F'cast | |
---|---|---|
Revenue | 15.3% | |
PBT | 163.7% | |
EPS | 209.9% | |
DPS | 2.2% |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 5,052.00 | 880.00 | 387.00¢ | 21.8 | n/a | -8% | 127.00¢ | 1.5% |
31-Dec-21 | 5,777.00 | 1,226.00 | 560.00¢ | 17.9 | 0.4 | +45% | 130.00¢ | 1.3% |
31-Dec-22 | 5,517.00 | 511.00 | 221.00¢ | 33.3 | n/a | -60% | 133.00¢ | 1.8% |
31-Dec-23 | 4,867.00 | 441.00 | 181.00¢ | 43.6 | n/a | -18% | 136.00¢ | 1.7% |
31-Dec-24 | 5,613.00 | 1,163.00 | 561.00¢ | 34.3 | 0.2 | +210% | 139.00¢ | 0.7% |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 7,134.62 | 1,555.01 | 759.46¢ | 33.7 | 1.0 | +35% | 141.88¢ | 0.0% |
31-Dec-26 | 8,147.60 | 2,153.11 | 1,004.23¢ | 25.5 | 0.8 | +32% | 145.96¢ | 0.0% |
31-Dec-27 | 9,298.18 | 2,899.44 | 1,286.03¢ | 19.9 | 0.7 | +28% | 149.14¢ | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Belgium's UCB to buy US-based Ra Pharmaceuticals... | 10-Oct-2019 | ShareCast |
GSK gets emerging markets boost with UCB deal | 24-Jan-2009 | Telegraph |
UCB confident on drug go-ahead | 21-Aug-2007 | The Scotsman |
Fellner shuffles Acambis board | 08-Mar-2007 | Telegraph |
Currency | Euro |
Share Price | 255.70 |
Change Today | -1.00 |
% Change | -0.39 % |
52 Week High | 260.20 |
52 Week Low | 129.35 |
Volume | 167,736 |
Shares Issued | 190.00m |
Market Cap | 48,583m |
Beta | 1.78 |
Strong Buy | 7 |
Buy | 11 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 21 |
Time | Volume / Share Price |
17:35 | 3 @ 255.70 |
17:35 | 486 @ 255.70 |
17:35 | 236 @ 255.70 |
17:35 | 90 @ 255.70 |
17:35 | 115 @ 255.70 |
You are here: research